A new study has found that people with age-related macular degeneration (AMD) are at greater risk of developing severe complications ...
Perth pharmaceutical company NeuroScientific Biopharmaceuticals (NSB) has announced its lead drug candidate slowed glaucoma-induced damage to the optic nerve, in ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited